Alternatives to Government-Imposed Price Controls to Lower US Drug Prices
JAMA Health Forum 10.1001/jamahealthforum.2025.5744October 23, 2025 at 11:00 AM EDT
This JAMA Forum discusses the limits of most-favored-nation pricing and other price controls on US drugs and provides policy alternatives, including generic and biosimilar competition, value-based pricing, and reforms to pharmacy benefit managers.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.